Moreover, research by Wang et al. demonstrated an elevation in methyltransferase-like protein 3 (METTL3) levels within the tumor-infiltrating myeloid cells (TIMs) extracted from colon carcinoma patient biopsies, an observation that was associated with a poor clinical outcome [19]. This evidence concerns the gene METTL3 and colon carcinoma.